Reports of Patent, Design, and Trade Mark Cases, Issues 1-5; Issues 8-13Published at the Patent Office Sales Branch, 2003 - Industrial property |
From inside the book
Results 1-3 of 80
Page 123
... application but the claimant may in fact not even know whether the compound can be produced in practice . If nothing further is added either by amendment or by further application , the application must fail and be refused . It would be ...
... application but the claimant may in fact not even know whether the compound can be produced in practice . If nothing further is added either by amendment or by further application , the application must fail and be refused . It would be ...
Page 184
... application shall be taken to be withdrawn . " An international application must therefore enter the United Kingdom national phase within a prescribed period , otherwise it will be treated as withdrawn under the Act . The period is ...
... application shall be taken to be withdrawn . " An international application must therefore enter the United Kingdom national phase within a prescribed period , otherwise it will be treated as withdrawn under the Act . The period is ...
Page 433
... application Inventive step Infringement - importation Infringement - joint tortfeasors Wesley Jessen Corp v CooperVision Ltd Ancare New Zealand Ltd's Patent Sabaf SpA v Meneghetti SpA Sabaf SpA v Meneghetti SpA [ 8 ] 264 Sabaf SpA v ...
... application Inventive step Infringement - importation Infringement - joint tortfeasors Wesley Jessen Corp v CooperVision Ltd Ancare New Zealand Ltd's Patent Sabaf SpA v Meneghetti SpA Sabaf SpA v Meneghetti SpA [ 8 ] 264 Sabaf SpA v ...
Other editions - View all
Common terms and phrases
ALBERTA FERRETTI amendment Amgen amino acid Appointed Person Arsenal FC Arsenal Football Club burner cell claim 19 claimant colour common general knowledge contact lens CooperVision Court of Appeal cross-examination Davies decision defendants Directive distinctive character DNA sequence dots earlier trade mark effect erythropoietin European Patent evidence filed gene hearing officer High Court Inc v Transkaryotic infringement Integer inventive step iris section issue judge judgment Kirin-Amgen Inc lenses likelihood of confusion Ltd's Trade Mark Marks Act 1994 Meneghetti non-use opponent paragraph numbers paras Patent Office Philips Electronics NV Plc v Reed prior art priority date protein question Quickfit reason Reed Business Information referred registered trade mark registrar relation relevant Remington Consumer Products revocation shape Silverleaf specification submissions Sweet & Maxwell Synthon third party TORRES TRADE MARK 2003 Trade Mark Application trade mark proprietor Trade Marks Act Transkaryotic Therapies Inc uEPO United Kingdom word